Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIK066 in Patients with Renal Impairment and Type 2 Diabetes
NCT03131479Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of licogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Apr 2017; status: completed.
02
Drugs
licogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03131479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03131479.